INTRODUCTION
Streptococcus pyogenes (group A streptococcus), a globally prominent cause of human disease, may give rise to a variety of acute infections, such as pharyngotonsillitis, impetigo, erysipelas, septicaemia and a generalized toxic syndrome. The non-suppurative sequelae, namely rheumatic fever and acute glomerulonephritis, characteristically associated with S . pyogenes are still highly prevalent in the developing world. The adaptation of S . pyogenes as an almost exclusively human pathogen may at least in part reside in its Abbreviation: OF, serum opacity factor.
The GenBank accession numbers for the nucleotide sequences reported in this paper are AF009908-AF009920.
unusual ability to interact with human plasma and matrix tissue components. Thus, M protein, a typespecific virulence factor conferring resistance to phagocytosis, has been known for some time to bind fibrinogen; whether such resistance is somehow related to the binding of fibrinogen has been debated (Whitnack et al., 1988 ; Fischetti, 1989 ). An interaction between M protein and another plasma protein, complement inhibitory factor H, was also proposed to account for its antiphagocytic effect, although recently this was not corroborated when isogenic mutants were studied (Horstmann et al., 1992; Perez-Casal et al., 1995) . Many strains of S . pyogenes bind the Fc parts of IgG or IgA, or both, as well as other plasma proteins through M-or M-like proteins, which show extensive immunochemical variation within the species (Fischetti, 1989 ). S. pyogenes may also bind and activate plasminogen (Berge & Sjobring, 1993; Ben Nasr et al., 1994) or directly bind plasmin (Lottenberg et al., 1994) , which might facilitate tissue spread of the organisms. During the last decade, several interactions between S. pyogenes and extracellular matrix components have been reported and also proposed to be of relevance for tissue adhesion and invasion. Many strains were, for example, found to be capable of binding fibronectin (Kuusela et al., 1985) , vitronectin (Chhatwal et al., 1987) , collagen (Speziale et al., 1987; Kostrzynska et al., 1989) or laminin (Switalski et al., 1984) . A surface protein with affinity for fibronectin, designated Sfb or protein F, has now been characterized in detail (Sela et al., 1993; Talay et al., 1993 Talay et al., ,1994 . This protein was also shown to be of importance for the attachment of the organisms to some host epithelial cells Okada et al., 1994) .
Another protein, exhibiting similar fibronectin-binding regions as protein Sfb, was recently discovered (Kreikemeyer et al., 1995) . In addition, an unrelated surface protein of S. pyogenes which exhibited dual binding of fibrinogen and fibronectin was reported (Courtney et al., 1994) . Finally, binding of fibronectin to streptococcal serum opacity factor (OF), a type-variable lipoproteinase of undefined biological role, was found (Rakonjac et al., 1995) . Obviously, the capacity of more than one streptococcal factor to bind a certain host molecule, such as fibronectin, suggests that this interaction may be of relevance for microbial survival. In the present work, it was revealed that streptococcal protein F binds fibrinogen in addition to fibronectin. It was, therefore, of interest to purify the protein in order to study its binding characteristics, in particular to find out whether the binding of fibrinogen and fibronectin, two host molecules sharing few structural or biological properties, took place through separate or common molecular sites. Furthermore, the amino acid sequence variability of protein F from some different M-types of S. pyogenes was studied.
METHODS
Bacterial strains. Streptococcus pyogenes strain EF1949, type M15, was the source of chromosomal DNA for gene cloning.
Escherichia coli JM109 was the host for vector and recombinant plasmids, and E. coli NM539 for the propagation of recombinant phages. E. coli HBlOl was used for highefficiency transformation after preparation of recombinant plasmids using the Erase-a-Base System (Promega). E. coli BL21(DE3) (Novagen) was the host strain used for expression of a fibrinogen-binding protein.
The following reference strains of S. pyogenes, obtained earlier from the respective laboratories, were tested for nucleotide sequence alignment of part of the prtF gene Haanes et al. (1992) . Lambda bacteriophage and plasmid DNA were isolated by standard procedures (Maniatis et al., 1982) . Plasmid DNA was also prepared by use of the Qiagen Plasmid Kit, according to the instructions of the manufacturer. DNA probes. Recombinant plasmid pDH76, containing the DNA fragment encoding the so-called A repeats of the streptococcal fcrA76 gene (Heath & Cleary, 1989) , was kindly provided by Professor P. P. Cleary, Department of Microbiology, University of Minnesota, Minneapolis, USA. The recombinant insert of plasmid pDH56, containing the major part of the fcrA76 gene, was labelled with digoxigenin and used as a probe for the fcrA gene. Molecular cloning. A gene library of strain EF1949 DNA in phage AGEMll (Promega) was obtained by established methods (Maniatis et al., 1982) . The Packagene in vitro packaging system (Promega) was used for packaging of ligated DNA into phage particles and plasmid pGEM7Zf( + ) (Promega) for subcloning in E. coli JM109. Expression plasmid vector pET-2la( + ) [or pET22b( + ) for the pEFGR153 clone] (Novagen) was used for the forced cloning of PCR fragments containing various fragments of a fibrinogen-binding protein gene. Preparation of competent cells of E. coli strains JM109, BL21 (DE3) or HB101, and transformation, were according to the Promega Protocols and Applications Guide. Phage manipulation, DNA restriction, ligation and agarose gel electrophoresis were carried out according to well-known protocols (Maniatis et al., 1982) . DNA hybridization analysis with digoxigenin-labelled A repeats of fcrA76 DNA probes was according to the instructions given in DIG DNA Labelling and Detection Kit (Boehringer-Mannheim) .
DNA sequencing. DNA was sequenced by the dideoxy chaintermination method (Sanger et al., 1977) . Overlapping doublestranded templates for sequencing were prepared with the Erase-a-Base System (Promega). Sequencing reactions were done with the Sequenase version 2.0 Kit (USB) from the SP6 or T7 promoter primers. PCR and primers. The PCR reaction was run in a 50 p1 format with a Minicycler (MJ Research) according to standard procedures (Saiki et al., 1988) . Primers used are listed in Table   1 . The primers forward/reverse 1 were selected to amplify a DNA fragment encoding the whole fibrinogen/fibronectinbinding protein, whereas in the case of primers forward/ reverse 2 the C-terminal, fibronectin-binding domains (Sela et al., 1993) were not included. The primers UFBDF/UFBDR were designed to amplify the upstream fibronectin-binding domain, primers FBREPF/FBREPR to amplify the fibronectinbinding (type 2) repeats, and primers FgREPF/FgREPR for the type 1 repeats. Purification of fibrinogen. Since it was found to be contaminated with fibronectin, commercial human fibrinogen (KABI-Pharmacia) was purified by absorption of fibronectin to gelatin-Sepharose as reported by Yamada (1982) with minor modifications. The concentration of fibrinogen was measured using the D, Protein Assay (Bio-Rad) and its purity was confirmed by SDS-PAGE and Western blot analysis. Fibronectin, as well as the immunoglobulin fractions of rabbit antisera specific for fibrinogen or fibronectin (Dakopatts), cording to the description of the manufacturer (Boehringer Mannheim) .
Isolation of recombinant fibrinogen-binding protein.
A fibrinogen-binding protein (protein F15) was purified from a sonicate extract of induced E. coli BLZl(DE3) cells harbouring recombinant expression plasmid pFNB3. Following fractionation with ammonium sulphate, the fraction which precipitated at 30 '/o saturation was applied to a column packed with Sephacryl S-200 HR (KABI-Pharmacia) and equilibrated with 15 mM phosphate-buffered saline (PBS) containing 10 mM benzamidine hydrochloride, pH 7.2. Fractions were collected and screened for fibrinogen-binding activity using digoxigenin-labelled fibrinogen as described below. Fractions exhibiting fibrinogen-binding activity were pooled and applied to a fibrinogen-Sepharose column in the same buffer. After washing, protein bound to the affinity matrix was eluted with 0.1 M glycine/HCl buffer, pH 2 8 , containing 10 mM benzphatase-labelled anti-digoxigenin antibody as detailed by the manufacturer (Boehringer). amidin; hydrochloride. Foliowing dialysis, the purity of the isolated protein was confirmed by SDS-PAGE and Western blotting using loadings of 5 pg of the purified fibrinogenbinding protein.
Rabbit antiserum to protein F15. The 30% ammonium sulphate precipitated fraction of the sonicate extract of the induced culture of E. coli BL21(DE3)(pFNB3) was used for immunization of rabbits in order to obtain antibodies to protein F15. At monthly intervals, 0.5 ml sonicate together with complete (initial injection) or incomplete (subsequent four injections) Freund's adjuvant was injected subcutaneously. The antiserum was extensively adsorbed with a mixture of sonicates of induced and non-induced E. coli BL21(DE3) harbouring vector plasmid pET2la( + ).
Western blotting. SDS-PAGE was done according to Laemmli (1970) . Electrotransfer of proteins from polyacrylamide gels was done by standard methods (Andersen, 1984) . After electroblotting, the nitrocellulose membrane was blocked with 3% skim milk (Oxoid) in PBS for 1 h. Fibrinogen-and fibronectin-binding proteins were detected by incubation with fibrinogen or fibronectin (20 g 1-l) followed by the respective antibody (dilution 1 : 2-50), peroxidase-labelled protein A (Sigma) and p-phenylenediamine for development. Alternatively, fibrinogen-binding proteins were detected by incubation for 1 h at 20 "C with digoxigenin-labelled fibrinogen (20 g 1-l) with subsequent development by alkaline-phosAffinity constant determinations. The association constants (K,) of protein F15 for fibrinogen and fibronectin in the liquid phase were determined as described by Friguet et al. (1985) with minor modifications. In brief. a constant amount of either fibrinogen or fibronectin was incubated at room temperature for 1 h with various quantities of protein F15. The amount of unbound fibrinogen or fibronectin was subsequently measured by indirect ELISA using protein F1S for coating of microtitre plates. The general scheme of the experiment is shown in Fig. 1 .
RESULTS

Isolation and sequencing of the gene of a fibrinogenbinding protein
A phage A library of S. pyogenes EF1949 (type M15), was screened for expression of proteins able to bind fibrinogen. Several positive recombinant clones were identified and tested for hybridization with the fcrA76 Arepeat probe to detect the fcrA15 gene encoding the FcRA1.5 fibrinogen-binding protein (Katerov et al., 1994) . Five positive phage clones which did not hybridize with the fcrA76 A-repeat probe, yet reacted with digoxigenin-labelled fibrinogen, were further analysed.
DNA from these phage clones was isolated and a restriction map was created for each of them. A 6 kb XbaI fragment was common to all five. A slightly larger SacI fragment of 8 kb from phage phFBll (Fig. 2) (Fig. 2) .
The 2801 nucleotide pairs of inserts of plasmids pFSXl and pFSKl were sequenced from a common SphI restriction site (Fig. 2) (GenBank accession number AF009908). One long ORF, starting from position 450 and finishing at position 2504, was found. This ORF (prtF) encoded a protein of 685 amino acid residues with extensive amino acid sequence relatedness (87 YO similarity, 79 YO identity) to the previously described fibronectin-binding protein, protein F (Sela et al., 1993) . As expected, the deduced protein F15 exhibited all typical features earlier described for S f b I or protein F of other serotypes (Sela et al., 1993; Talay et al., 1993 Talay et al., , 1994 . It contained a signal polypeptide 56 amino acids in length, a variable region, five type 1 repeats of unknown function, a spacer region, an upstream fibronectinbinding domain (UFBD), four fibronectin-binding repeats and a C-terminal region typical for streptococcal surface proteins (Fig. 2) .
Since the principal cell-surface-associated virulence factor of S. pyogenes, the M protein, exhibits extensive Nterminal sequence variation, thereby complicating vaccine development, we studied whether this would apply to protein F as well, knowing that gene variability occurred mainly in the N-terminal part (Talay et al., 1994) . T o analyse the extent of sequence diversity within the variable region (Talay et al., 1994) , approximately 300 nucleotides from the signal sequence cleavage site were determined for an additional 12 S . pyogenes strains of different M-serotypes. The alignment of this part of the gene for protein F of the present M15 strain, the 12 other strains and the previously described protein F gene sequence is shown in Fig. 3(a) . Aligning all strains, six types of nucleotide pattern were distinguished between nucleotide positions 60 and 270 (Fig. 3b) . Several nucleotide sequence variation patterns can be easily identified even by visual inspection. The differences between sequence patterns indicate that a number of recombination events as well as point mutations occurred in the evolution of prtF genes. Notably, a mosaic-like structure of the variable region can readily be observed, for instance by comparing the nucleotide sequences for strains M4 (281C), M4 (UmeA), M18 (SS-36), M12 (195/2110) and M12 (100085) , where the sequences show a common pattern up to position 59 and then segregate to different variant types. Furthermore, a unique block between nucleotide positions 76 and 111 was present in only three sequences out of 14; however, two of them were of sequence type I whereas the third one was of type I1 (Fig. 3b) . The sequence variability was not as high as for M-or M-like proteins and there was no strict correlation of serotype or OF expression between different nucleotide sequence patterns. The substitution of DNA sequences observed was most probably due to horizontal genetic transfer, a mechanism also found for other streptococcal virulence genes (Whatmore & Kehoe, 1994; Kapur et al., 1995) .
Characterization of protein F15
To obtain recombinant protein F15 for purification and biochemical investigation the prtF gene was amplified and cloned into the pET-2la( +) expression vector through BamHI and SacI restriction sites introduced to the gene sequence with PCR primers (see primer sequences in Table 1 and Methods). The resulting plasmid, pFNB3, was able to express the protein in E. coli strain BL21(DE3) after induction with IPTG (Figs 4  and 5) . For E . coli strain BL21 (DE3) harbouring plasmid pET-2la(+) without any M-type 15 DNA insert no fibrinogen-or fibronectin-binding activity was observed (Fig. 5) .
Protein F15 was purified from a sonicate extract of the recombinant E. coli strain carrying pFNB3. The protein eluted from fibrinogen-Sepharose revealed a single polypeptide band by Coomassie brilliant blue staining after SDS-PAGE and showed reactivity with labelled fibrinogen as well as fibronectin. The protein, when present in crude E . coli extract, was stable during longterm storage at 4 "C. Following purification, however, the binding activity for fibrinogen was lost within 48 h, whereas the binding of fibronectin was retained for at least 4 weeks. As tested during purification, the protein was particularly sensitive to a pH lower than 4.0, perhaps due to protease activation, and the presence of a protease inhibitor was therefore essential to its recovery.
The apparent molecular mass of protein F15 was approximately 100 kDa (Fig. 4) , which is higher than that predicted from the deduced amino acid sequence of the recombinant protein. Since it is known that fibrinogen interacts with fibronectin, it was possible that the binding of commercial fibrinogen to protein F15 was in fact due to its content of fibronectin. The preparation was therefore fractionated on collagen-Sepharose to remove any fibronectin. The binding of fibrinogen to protein F1.5 was unaffected by this purification step. The purity of the fibrinogen and authenticity of the detection system used were confirmed by Western blot tests with fibronectin-and fibrinogen-specific antibodies (data not shown). The ability of protein F1.5 to bind other plasma and extracellular matrix proteins was also investigated. Fibrinogen, fibronectin, IgG1, IgG2, IgG3, IgG4, IgA, IgD, IgM, laminin, vitronectin , the complement component Clq, collagen and serum albumin were examined by the dot-blot technique, at an initial load of approximately 4 pg of each protein. Protein F15 exhibited binding above background control levels to only fibrinogen and fibronectin (data not shown).
The affinity constants of the interactions of protein F15 with fibronectin and fibrinogen were determined by ELISA. The experiments demonstrated that protein F15 bound fibronectin with higher affinity ( K , 1.8 x lo8 mol-l) than it bound fibrinogen ( K , 1-25 x lo' mol-l).
Mapping of the binding region for fibrinogen
A truncated variant of protein F15, lacking the Cterminal half, was obtained by expression in E. coli BL21 (DE3) of the recombinant plasmid pEFNB31, containing a prtF1.5 gene fragment generated by PCR using primers ' forward ' and ' reverse 2 ' (see Table 1 and Figs 2 and 5a). As tested with sonicate extracts of E. coli BL21 (DE3) , containing the respective recombinant plasmids, the protein did not show any detectable binding of fibronectin but still bound fibrinogen. Two recombinant polypeptides expressed from recombinant plasmids pEUFBD1.5 and pEFBR154, representing the upstream fibronectin-binding domain and fibronectin-binding repeats, bound fibronectin as expected but failed to bind fibrinogen. The polypeptide expressed from plasmid pEFGR1.53, covering the type 1 sequence repeats, failed to bind either fibrinogen or fibronectin. Recombinant plasmid pEUD15 was generated by AvaI digestion of the plasmid pEFNB31 with subsequent filling to blunt ends and ligation. The polypeptide expressed from this plasmid encompassed the variable N-terminal part of protein F15 and exhibited binding of fibrinogen but not fibronectin. The rabbit antiserum to protein F15, similarly to fibrinogen, showed preferential binding to the N-terminal part of the protein F1.5 molecule (Fig. 5) .
DISCUSSION
It is known that the FcRA proteins of some OF-positive Protein F of S. pyogenes serotypes of S. pyogenes bind fibrinogen in addition to IgG (Stenberg et al., 1992) . From the present strain of serotype M1.5, the gene for the FcRA protein was cloned and sequenced (Katerov et al., 1994) . It was found, as expected, that recombinant FcRA1.5 protein bound fibrinogen and IgG with high affinity. However, the original streptococcal strain demonstrated high binding of fibrinogen (unpublished data) but only moderate binding of IgG. It was therefore possible that the strain could express more than one fibrinogen-binding protein on its surface. In the present work, a gene larger than the fcrA2.5 gene, encoding a fibrinogen-binding protein, was identified. Surprisingly, nucleotide sequence comparison of the cloned gene with known genes of S. pyogenes revealed extensive sequence similarity and identity with the gene encoding the fibronectin-binding protein F. This protein (designated F1.5), hitherto described as a principal epithelial adhesin, might therefore have additional biological properties of possible importance for the virulence of S. pyogenes.
Previously, only the fibronectin-binding region, representing approximately 30 % of the whole molecule, was isolated (Sela et al., 1993) . In the present work, the entire recombinant protein F1.5 was successfully purified by a combination of gel filtration and fibrinogen affinity chromatography. Although stable on the streptococcal surface or in crude extracts of recombinant E. coli expressing protein F1.5, the protein was increasingly sensitive to degradation during purification. Since the binding of fibronectin was of higher affinity than that of fibrinogen, use of a fibronectin rather than fibrinogen affinity sorbent would seem preferable. On the other hand, the stronger elution conditions required in such case might possibly affect the stability of the protein and therefore cause failure of purification. Purified protein F1.5 was tested for interaction with different plasma and extracellular matrix proteins and no binding to proteins other than fibronectin and fibrinogen was found. Also the binding constant for fibrinogen, although lower compared to that for fibronectin, indicated a specific interaction between protein F1.5 and fibrinogen. The results with recombinant subfragments of protein F1.5 established that human fibrinogen binds to the N-terminal end of protein F15, which is clearly distinct from the parts of the molecule interacting with fibronectin determined earlier by others and corroborated here (Fig. 5 ) . Our examination using a rabbit antiserum raised to crude preparations of protein F1.5 also indicated that the N-terminal end of the protein F1.5 molecule may be immunodominant. Whether antibodies with such specificity might protect against colonization with S. pyogenes is so far unknown.
The biological role of the dual binding affinity of protein F1.5, shared with certain M-family proteins (Schmidt et al., 1993) as well as another, unrelated protein of this species (Courtney et al., 1994) , remains to be clarified.
Binding of fibrinogen was claimed to be essential to the antiphagocytic effect of M protein (Whitnack et al., 1988) , and the closely related FcRA proteins, also binding fibrinogen, have been found to account for some antiphagocytic properties (Podbielski et al., 1996) . Since protein F appears to be involved in the binding of streptococci to various epithelial cells, the use of the protein for immune prophylaxis against S. pyogenes should be of interest. The information obtained in the present work indicates that, compared to the extensive antigenic variation of streptococcal M protein, the diversity of protein F may be more limited, which should be advantageous for such potential use.
